Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04811963 · ClinicalTrials.gov registry record
SpO2 Accuracy Low Saturation Validation of the OxySoftN Sensor
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 10
- Enrollment target
NCT04811963 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 10 participants.
The verdict
NCT04811963 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
To compare prototype pulse oximeter saturation measurements, during normal to low saturation, to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from healthy human subjects.
Interventions
- DEVICE Non-Invasive Controlled Hypoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-04-06 |
| Est. Completion | 2021-04-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04811963
The ClinicalTrials.gov registry entry for NCT04811963 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Non-Invasive Controlled Hypoxia is the first listed.
NCT04811963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04811963 about?
NCT04811963 is a clinical study titled "SpO2 Accuracy Low Saturation Validation of the OxySoftN Sensor". To compare prototype pulse oximeter saturation measurements, during normal to low saturation, to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from healthy human subjects.
What is the current status of trial NCT04811963?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2021-04-06. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT04811963?
The interventions under investigation include: Non-Invasive Controlled Hypoxia (DEVICE).
Who is sponsoring clinical trial NCT04811963?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.